AMAG Pharmaceuticals continues to support healthcare providers and patient advocacy organizations invested in the fight against prematurity. AMAG Pharmaceuticals is dedicated to playing an active role in helping reduce the preterm birth rate through collaboration with healthcare providers to advance patient care, ongoing research and development, and partnering in community educational initiatives.
With Makena Care Connection®, you get more than Makena® (hydroxyprogesterone caproate). You’ll get personalized support specifically designed to help you throughout your experience with Makena, including:
A downloadable PDF is available to help you understand how Makena Care Connection provides an extra layer of support during your pregnancy.
Miracle Babies provides support and financial assistance to families with critically ill newborns in the Neonatal Intensive Care Unit; and to enhance the well-being of women, children and their families through education, prevention and medical care. To learn more, visit www.miraclebabies.org.
AMAG Pharmaceuticals is a proud corporate partner of Sidelines. Our partnership helps advance the mission of Sidelines of providing support for women and their families experiencing complicated pregnancies and premature births. To learn more about how Sidelines can support your high-risk patients, please visit www.sidelines.org.
Makena (hydroxyprogesterone caproate injection) is a progestin indicated to reduce the risk of preterm birth in women with a singleton pregnancy who have a history of singleton spontaneous preterm birth. The effectiveness of Makena is based on improvement in the proportion of women who delivered <37 weeks of gestation. There are no controlled trials demonstrating a direct clinical benefit, such as improvement in neonatal mortality and morbidity.
Limitation of use: While there are many risk factors for preterm birth, safety and efficacy of Makena has been demonstrated only in women with a prior spontaneous singleton preterm birth. It is not intended for use in women with multiple gestations or other risk factors for preterm birth.
Please see full Prescribing Information for Makena.